DexCom DXCM
Valuation
Multiples measured against the stock's own five-year history
Near the bottom of its 5-year range · 6th percentile, 5-year average 105.6x
#2262 of 2996 stocks by PE (1 = cheapest)
Below its usual level · 23rd percentile, 5-year average 16.3x
#5057 of 5338 stocks by PB (1 = cheapest)
Near the bottom of its 5-year range · 9th percentile, 5-year average 10.9x
#4175 of 5161 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 11.67 | – | 16.31 | 23% (cheaper than usual) | #5057 of 5338 (1 = cheapest) |
| PE | 31.23 | 27.30 | 105.58 | 6% (cheaper than usual) | #2262 of 2996 (1 = cheapest) |
| PS | 5.80 | 5.27 | 10.94 | 9% (cheaper than usual) | #4175 of 5161 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on DXCM.
Sign in to join the discussion.